Biology Reference
In-Depth Information
[196]
Van der Stelt, M., Fox, S.H., Hill, M., Crossman, A.R., Petrosino, S., Di Marzo, V.,
Brotchie, J.M. (2005). A role for endocannabinoids in the generation of parkinsonism
and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of
Parkinson's disease.
Faseb J
, 19, 1140-1142.
[197]
Van der Stelt, M., Mazzola, C., Esposito, G., Matias, I., Petrosino, S., De Filippis, D.,
Micale, V., Steardo, L., Drago, F., Iuvone, T., Di Marzo, V. (2006). Endocannabinoids
and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of
endocannabinoid levels.
Cell Mol Life Sci
, 63, 1410-1424.
[198]
Van Gaal, L., F.Rissanen, A., M.Scheen, A.J., Ziegler, O., Rossner, S. (2005). Effects
of the cannabinoid-1 receptor blocker rimonabant on weight reduction and
cardiovascular risk factors in overweight patients: 1-year experience from the RIO-
Europe study.
Lancet
, 365, 1389-1397.
[199]
Van Sickle, M.D., Duncan, M., Kingsley, P.J., Mouihate, A., Urbani, P., Mackie, K.,
Stella, N., Makriyannis, A., Piomelli, D., Davison, J.S., Marnett, L.J., Di Marzo, V.,
Pittman, Q.J., Patel, K.D., Sharkey, K.A. (2005). Identification and functional
characterization of brainstem cannabinoid CB2 receptors.
Science
, 310, 329-332.
[200]
Varma, N., Carlson, G.C., Ledent, C., Alger, B.E. (2001). Metabotropic glutamate
receptors drive the endocannabinoid system in hippocampus.
J Neurosci
, 21, RC188.
[201]
Varvel, S.A., Lichtman, A.H. (2002) Evaluation of CB1 receptor knockout mice in the
Morris water maze.
J Pharmacol Exp Ther
,
301
, 915-924.
[202]
Vaughan, C.W., Connor, M., Bagley, E.E., Christie, M.J. (2000). Actions of
cannabinoids on membrane properties and synaptic transmission in rat periaqueductal
gray neurons in vitro.
Mol Pharmacol
, 57, 288-295.
[203]
Vaughan, C.W., McGregor, I.S., Christie, M.J. (1999). Cannabinoid receptor activation
inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in
vitro.
Br J Pharmacol
, 127, 935-940.
[204]
Vincent, P., Armstrong, C.M., Marty, A. (1992). Inhibitory synaptic currents in rat
cerebellar Purkinje cells: modulation by postsynaptic depolarization.
J Physiol
, 456,
453-471.
[205]
Vincent, P., Marty, A. (1993). Neighboring cerebellar Purkinje cells communicate via
retrograde inhibition of common presynaptic interneurons.
Neuron
, 11, 885-893.
[206]
Vincent, P., Marty, A. (1996). Fluctuations of inhibitory postsynaptic currents in
Purkinje cells from rat cerebellar slices.
J Physiol
, 494 (Pt 1), 183-199.
[207]
Wagner, J.A., Varga, K., Jarai, Z., Kunos, G. (1999). Mesenteric vasodilation mediated
by endothelial anandamide receptors.
Hypertension
, 33, 429-434.
[208]
Walker, J., M., Huang, S.M. (2002). Endocannabinoids in pain modulation.
Prostaglandins Leukot Essent Fatty Acids
, 66, 235-242.
[209]
Wartmann, M., Campbell, D., Subramanian, A., Burstein, S.H., Davis, R.J. (1995). The
MAP kinase signal transduction pathway is activated by the endogenous cannabinoid
anandamide.
FEBS Lett
, 2-3, 133-136.
[210]
Watson, S.J., Benson, J., A., Jr., Joy, J.E. (2000). Marijuana and medicine: assessing
the science base: a summary of the 1999 Institute of Medicine report.
Arch Gen
Psychiatry
, 57, 547-552.
[211]
Wilson, R., I.Kunos, G., Nicoll, R.A. (2001). Presynaptic specificity of
endocannabinoid signaling in the hippocampus.
Neuron
, 31, 453-462.
